tumor biomarkers - Robuta Search

https://www.ncbi.nlm.nih.gov/books/NBK597378/ Laboratory Evaluation of Tumor Biomarkers - StatPearls - NCBI Bookshelf Tumor biomarkers are substances synthesized by cancer cells or other body cells in response to cancer and released into the circulation.[1] Tumor biomarkers... tumor biomarkers laboratory evaluation ncbi bookshelf https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1206800/full Frontiers | Novel insights into biomarkers of progression in Desmoid tumor Desmoid tumor (DT) is a rare neoplasm characterized by the proliferation of myofibroblastic cells that infiltrates and invades adjacent tissues. Due to its l... novel insights frontiers biomarkers progression desmoid https://pmc.ncbi.nlm.nih.gov/articles/PMC12082508/ Diagnostic efficiency of peripheral tumor serum biomarkers in lung cancer and their correlation... Objective: To investigate the clinical value of serum tumor markers - carcinoembryonic antigen (CEA), endothelial cell-specific molecule-1 (ESM-1),... https://openresearch.surrey.ac.uk/esploro/outputs/journalArticle/Can-circulating-tumor-and-exosomal-nucleic/991110186702346 Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal... Jul 3, 2019 - Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma? - University of Surrey - Journal article https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1510503/full Frontiers | Multi-omics analysis identifies UBA family as potential pan-cancer biomarkers for tumor... BackgroundUBA1 and UBA6 are classic ubiquitin-activating E1 enzymes, which participate in the ubiquitination degradation of intracellular proteins and are cl... https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2019.00119/full Frontiers | Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events In the last decade, inhibitors targeting immune checkpoint molecules such as cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death 1 (PD-1) and pr... immune checkpoint https://boris-portal.unibe.ch/entities/publication/98e6fd3a-7f41-43fa-88fd-4772639927ce Circulating tumor cells as trigger to hematogenous spreads and potential biomarkers to predict the... Despite several improvements in the surgical field and in the systemic treatment, ovarian cancer (OC) is still characterized by high recurrence rates and... circulating tumor cells https://about.uq.edu.au/experts/project/63606 Interrogating the Prostate Tumor Microenvironment for Circulating Radiotherapy Biomarkers to... the prostate tumor microenvironment interrogating circulating radiotherapy https://researchconnect.buffalo.edu/en/publications/tumor-specific-immune-responses-and-biomarkers-in-pediatric-patie/ Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin... https://scholars.cityu.edu.hk/en/publications/corrigendum-biomarkers-and-computational-models-for-predicting-ef/ Corrigendum: Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy... computational models https://pubmed.ncbi.nlm.nih.gov/33142739/ The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in... Over the last years has emerged the urgent need for the identification of reliable prognostic biomarkers able to potentially identify metastatic... https://experts.colorado.edu/display/meshid_D23.101.140.642 Biomarkers, Tumor - Receptor, ErbB-2 | CU Experts | CU Boulder biomarkers tumor receptor erbb cu